-
-
Ključne reči:
-
Sažetak
-
Reference
[1]F. Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, L. A. Torre,and A. Jemal, “Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,” CA: a cancer journal for clinicians, vol. 68,no.6,pp.394-424,2018.
[2] A. Colquhoun, M. Arnold, J. Ferlay, K. J. Goodman, D. Forman,and I. Soerjomataram, “Global patterns of cardia and non-cardia gastric cancer incidence in 2012,” Gut ,vol. 64,no.12,pp.1881-1888,2015.
[3]Japanese Gastric Cancer Association. “Japanese classification of gastric carcinoma: 3rd English edition.” Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 14,no.2 ,101-12,2011.
[4]S. Kamiya, H. Takeuchi, T. Nakahara, M. Niihara, R. Nakamura,T. Takahashi, N. Wada, H. Kawakubo ,Y. Saikawa, T. Omori, K. Murakami,and Y. Kitagawa, “Auxiliary diagnosis of lymph node metastasis in early gastric cancer using quantitative evaluation of sentinel node radioactivity,” Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 19,no.4 ,pp.1080-1087,2016.
[5]S. H.Noh, W. J. Hyung, and J. H. Cheong, “Minimally invasive treatment for gastric cancer: approaches and selection process,” Journal of surgical oncology, vol. 90,no.3,pp.188-193,2005.
[6]J. X. Lin, Z. K. Wang, W. Wang, J. Desiderio,J. W. Xie, J. B. Wang, J. Lu, Q. Y. Chen, L. L. Cao , M. Lin, R. H. Tu,C. H. Zheng, P. Li, A. Parisi, Z. W. Zhou, and C. M. Huang, “Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data,” BMC cancer, vol. 19,no.1 ,pp.1048,2019.
[7]J. Mu, Z. Jia, W. Yao, J. Song, X. Cao, J. Jiang, and Q. Wang, “Predicting lymph node metastasis in early gastric cancer patients: development and validation of a model,” Future oncology (London, England), vol. 15,no.31,pp.3609-3617,2019.
[8]Y. W.Wang, M. L.Zhu , R. F.Wang , W. J.Xue,X. R. Zhu, L. F.Wang, and L. Z.Zheng,“Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers, ” Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37,no. 7, pp. 8567–8578, 2016.
[9]Y.Zhou, Y. Li, J. Zheng, K. Liu and H.Zhang, “Detecting of gastric cancer by Bcl-2 and Ki67,” International journal of clinical and experimental pathology, vol.8, no.6, pp. 7287–7290,2015.
[10] I. D. Nagtegaal, R. D. Odze, D. Klimstra, V. Paradis, M. Rugge, P. Schirmacher, K. M. Washington, F. Carneiro, I. A. Cree, and WHO Classification of Tumours Editorial Board,“The 2019 WHO classification of tumours of the digestive system,” Histopathology,vol. 76,no.2 ,pp.82-188,2020.
[11] S. Tanaka, H. Kashida, Y. Saito, N. Yahagi, H. Yamano, S. Saito, T. Hisabe, T. Yao, M. Watanabe, M. Yoshida, Y. Saitoh, O. Tsuruta, K. I. Sugihara, M. Igarashi, T. Toyonaga, Y. Ajioka, M. Kusunoki, K. Koike, K. Fujimoto, and H. Tajiri, “Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection,” Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, vol. 32,no.2,pp.219-239,2020.
[12]S.Wang,L. Xu, Q. Wang, J. Li, B. Bai, Z. Li, X.Wu, P. Yu, X. Li, and J.Yin, “Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies,” World journal of surgical oncology, vol.17,pp.1,pp. 52,2019.
[13]S. M. Kim, B. H. Min, J. H. Ahn, S. H. Jung, J. Y. An, M. G. Choi, T. S. Sohn , J. M. Bae, S. Kim, H. Lee, J. H. Lee, Y. W. Kim, K. W. Ryu, J. J. Kim, and J. H. Lee, “Nomogram to predict lymph node metastasis in patients with early gastric cancer: a useful clinical tool to reduce gastrectomy after endoscopic resection,” Endoscopy, vol. 52,no.6 ,pp.435-443,2020.
[14]J. Chen, G. Zhao, and Y. Wang, “Analysis of lymph node metastasis in early gastric cancer: a single institutional experience from China,” World journal of surgical oncology, vol. 18,no.1,pp.57,2020.
[15]Y. Gunji, T. Suzuki, S. Hori, H. Hayashi, H. Matsubara, H. Shimada, and T. Ochiai, “Prognostic significance of the number of metastatic lymph nodes in early gastric cancer,” Digestive surgery, vol. 20,no.2,pp.148-532003.
[16]J. Du, Y. Shen, W. Yan , and J. Wang, “Risk factors of lymph node metastasis in the splenic hilum of gastric cancer patients: a meta-analysis.” World journal of surgical oncology, vol. 18,no.1 ,pp.233,2020.
[17]D. Dong, M. J. Fang, L. Tang, X. H. Shan, J. B. Gao, F. Giganti, R. P. Wang, X. Chen, X. X. Wang, D. Palumbo, J. Fu, W. C. Li, J. Li, L. Z. Zhong, F. De Cobelli, J. F. Ji, Z. Y. Liu, and J. Tian, “Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study,” Annals of oncology : official journal of the European Society for Medical Oncology, vol. 31,no.7,pp.912-920,2020.
[18]Z.Wang, J. Liu, Y. Luo, Y. Xu, X. Liu, L. Wei,and Q. Zhu, “Establishment and verification of a nomogram for predicting the risk of lymph node metastasis in early gastric cancer,” Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, vol. 113,no.6,pp. 411-417,2021.
[19]M. Sekiguchi, I. Oda, H. Taniguchi, H. Suzuki, S. Morita, T. Fukagawa, S. Sekine, R. Kushima , H. Katai, “Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer,” Journal of gastroenterology, vol. 51,no.10 ,pp.961-970,2016.
[20]M. A. Pereira, M. Ramos, A. R. Dias, S. F. Faraj, O. K. Yagi, A. V. Safatle-Ribeiro, F. Maluf-Filho, B. Zilberstein, I. Cecconello , E. S. de Mello, and U. Jr Ribeiro, “Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer After Optimal Surgical Treatment,” Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract ,vol. 22,no.1 ,pp.23-31,2018.
[21]E. H. Jin, D. H. Lee, S. A. Jung, K. N. Shim, J. Y. Seo, N. Kim, C. M. Shin, H.Yoon, and H. C. Jung, “Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer,” World journal of gastroenterology,vol. 21,no.2,571-577,2015.
[22] U. Ronellenfitsch, C. Lippert, R. Grobholz, S. Lang, S. Post, G. Kähler, and T. Gaiser, “Histology-based prediction of lymph node metastases in early gastric cancer as decision guidance for endoscopic resection,” Oncotarget ,vol. 7,no.9 ,pp.10676-10683,2016.
[23]S. Y. Oh, K. G. Lee, Y. S. Suh, M. A. Kim, S. H. Kong, H. J. Lee, W. H Kim, and H. K. Yang, “Lymph Node Metastasis in Mucosal Gastric Cancer: Reappraisal of Expanded Indication of Endoscopic Submucosal Dissection,” Annals of surgery, vol. 265,no.1,pp.137-142,2017.
[24] H. Feng, Y. Wang, L. Cao , C. Zhang, B. Sun, Y. Zhao, and J. Xu, “Lymph node metastasis in differentiated-type early gastric cancer: a single-center retrospective analysis of surgically resected cases, ” Scandinavian journal of gastroenterology,vol. 51,no.1,pp.48-54,2016.
[25]B. Zhao, R. Huang, H. Lu, D. Mei, S. Bao, H. Xu, and B. Huang, “Risk of lymph node metastasis and prognostic outcome in early gastric cancer patients with mixed histologic type,” Current problems in cancer, vol. 44,no.6, pp.100579,2020.
[26]S. Karim and A. Ali, “Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India,” World Journal of Gastroenterology, vol. 15,no. 11, pp. 1381-1387,2009.
[27]M.Victorzon, S. Nordling, C. Haglund, J. Lundin, and P. J.Roberts, “Expression of p53 protein as a prognostic factor in patients with gastric cancer,” European journal of cancer (Oxford, England: 1990), vol.32A,no.2, pp.215-220,1996.
[28] Zhang Y, Zhao Q, Ren Y, Zhang P, Zheng Y. Clinicopathological Significance and Molecular Mechanism of AKT/GSK3β Pathway-based Fibrillin-1 Expression in Gastric Cancer Progression: AKT/GSK3β in Gastric Cancer. Cell Mol Biol (Noisy-le-grand). 2022 Aug. 31;68(8):57-63. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4493.
[29] Xiao M, Zhang Z, Liao G, Liu M, Chen X. Analysis of the Value of Helicobacter pylori Test in Combination with the Determination of Plasma Propepsin and Gastrin 17 in Screening the Precancerous Status of Gastric Cancer : H. pylori Test, Plasma Propepsin and Gastrin 17 in Gastric Cancer. Cell Mol Biol (Noisy-le-grand). 2022 Aug. 31;68(8):110-5. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4503.
[30] Li M, Zheng G, Yu L, Tan L- lian, Li X, Li M-J, Li C, Li S, Liang J, Zhong Z, Li ZM. Diagnostic value of MRI-DWI signal intensity value combined with serum PGI, PGII and CA199 in early gastric cancer. Cell Mol Biol (Noisy-le-grand). 2021 Aug. 31;67(2):95-100. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/3980.
[31] He L, Zhou Y. Evaluation of increased microRNA-21 in the serum of patients with cardia cancer: MiR-21 in serum of cardia cancer patients. Cell Mol Biol (Noisy-le-grand). 2022 Apr. 30;68(4):60-5. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4366.
[32] Dai Y, Yang G, Yang L, Jiang L, Zheng G, Pan S, Zhu C. Expression of FOXA1 gene regulates the proliferation and invasion of human gastric cancer cells. Cell Mol Biol (Noisy-le-grand). 2021 Aug. 31;67(2):161-5. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/3991.
[33] Chen B, Zhang J, Ma Q. The relationship between the simultaneity present of cagA and hopQI genes in Helicobacter pylori and the risk of gastric cancer. Cell Mol Biol (Noisy-le-grand). 2021 Aug. 31;67(2):121-6. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/3984.
[34] Guo X, Yin B, Wang C, Huo H, Aziziaram Z. Risk assessment of gastric cancer in the presence of Helicobacter pylori cagA and hopQII genes. Cell Mol Biol (Noisy-le-grand). 2022 Jan. 2;67(4):299-305. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4063.
[35] Zheng W, Tian X, Fan J, Jiang X, He W. Application of Dexmedetomidine in Surgical Anesthesia for Gastric Cancer and Its Effects on IL-1β, IL-6, TNF-α and CRP: Application of Dex in surgical anesthesia for gastric cancer. Cell Mol Biol (Noisy-le-grand). 2023 Mar. 31;69(3):177-81. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4722.
[36] Zheng X, Chen P, Liu Y, Wang B, Liu Q. Determining the relationship between cytokeratin expression and prognostic factors in human gastric cancer. Cell Mol Biol (Noisy-le-grand). 2022 Feb. 27;67(6):311-7. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4184.
[37] Guo W, Jia L, Wang D, Wang Z, Li R, Xue Z. Trop2 Promotes Vimentin Expression and Induces Epithelial Stromal Transformation, Invasion and Metastasis of Gastric Cancer Cells by Regulating β-Catenin: Trop2 Promotes Vimentin Expression. Cell Mol Biol (Noisy-le-grand). 2023 Jan. 31;69(1):93-7. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4653.
[38] Tian X. Influences of Etomidate Combined with Propofol on Cognitive Function, Inflammation and Immunity in Patients Undergoing Gastric Cancer Surgery: Etomidate and Propofol on Gastric Cancer Surgery. Cell Mol Biol (Noisy-le-grand). 2023 Apr. 30;69(4):81-5. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4744.
[39] Qi M, Liu D, Wang H, Bianba C, Ji W. Relationship between glutathione S-transferase M1 gene polymorphism and gastric cancer: baijiaochui07143@163.com. Cell Mol Biol (Noisy-le-grand). 2022 Dec. 31;68(12):49-53. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4626.
[40] Wang G, Jiang X. Effect of PRECEDE-PROCEED-Model-Based Health Education on the Life Quality and 5-HTT Gene Expression of Patients with Gastric Cancer after Surgery. Cell Mol Biol (Noisy-le-grand). 2022 Feb. 27;67(6):242-8. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4175.
[41] Ismail S, Naveed Mushtaq M, Shabbir U, Saima, Razzaq A, Ramzan HM, Shoukat A, Ahsan H, Movafagh A, Kahrizi D, Anjum I. Evaluation of Hepatoprotective and Gastroprotective Activities of Paspalidium flavidum Leaves Extract in Experimental Animal Models: Hepato- and gastroprotective effect of Paspalidium flavidum. Cell Mol Biol (Noisy-le-grand). 2022 Sep. 30;68(10):8-14. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4555.
[42] Kazemi, E., & Kahrizi, D. (2017). The repeatability of PCR-RFLP method for study of association between gastric cancer and manganese superoxide dismutase mutant (Val-9Ala). Biharean Biologist, 11(2), 112-114.
[43] Kazemi, E. and Kahrizi, D. (2016). Lack of association between gastric cancer and hopq alleles in Helicobacter pylori. Genetika. 48(3): 893-902. https://doi.org/10.2298/gensr1603893k.
[44] Kazemi, E., Kahrizi, D., Moradi, M.T. Sohrabi and Yari, K. (2016). Gastric Cancer and Helicobacter pylori: Impact of hopQII Gene. Cellular and Molecular Biology. 62(2): 107-110. https://doi.10.14715/cmb/2016.62.2.18.
[45] Kazemi, E., Kahrizi, D., Moradi, M.T. Sohrabi, M., Amini, A., Mousavi, S.A.R. and Yari, K. (2016). Association between Helicobacter pylori hopQI genotyping and human gastric cancer. Cellular and Molecular Biology. 62(1): 6-9. https://doi.10.14715/cmb/2016.62.2.18.
[2] A. Colquhoun, M. Arnold, J. Ferlay, K. J. Goodman, D. Forman,and I. Soerjomataram, “Global patterns of cardia and non-cardia gastric cancer incidence in 2012,” Gut ,vol. 64,no.12,pp.1881-1888,2015.
[3]Japanese Gastric Cancer Association. “Japanese classification of gastric carcinoma: 3rd English edition.” Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 14,no.2 ,101-12,2011.
[4]S. Kamiya, H. Takeuchi, T. Nakahara, M. Niihara, R. Nakamura,T. Takahashi, N. Wada, H. Kawakubo ,Y. Saikawa, T. Omori, K. Murakami,and Y. Kitagawa, “Auxiliary diagnosis of lymph node metastasis in early gastric cancer using quantitative evaluation of sentinel node radioactivity,” Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, vol. 19,no.4 ,pp.1080-1087,2016.
[5]S. H.Noh, W. J. Hyung, and J. H. Cheong, “Minimally invasive treatment for gastric cancer: approaches and selection process,” Journal of surgical oncology, vol. 90,no.3,pp.188-193,2005.
[6]J. X. Lin, Z. K. Wang, W. Wang, J. Desiderio,J. W. Xie, J. B. Wang, J. Lu, Q. Y. Chen, L. L. Cao , M. Lin, R. H. Tu,C. H. Zheng, P. Li, A. Parisi, Z. W. Zhou, and C. M. Huang, “Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data,” BMC cancer, vol. 19,no.1 ,pp.1048,2019.
[7]J. Mu, Z. Jia, W. Yao, J. Song, X. Cao, J. Jiang, and Q. Wang, “Predicting lymph node metastasis in early gastric cancer patients: development and validation of a model,” Future oncology (London, England), vol. 15,no.31,pp.3609-3617,2019.
[8]Y. W.Wang, M. L.Zhu , R. F.Wang , W. J.Xue,X. R. Zhu, L. F.Wang, and L. Z.Zheng,“Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers, ” Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 37,no. 7, pp. 8567–8578, 2016.
[9]Y.Zhou, Y. Li, J. Zheng, K. Liu and H.Zhang, “Detecting of gastric cancer by Bcl-2 and Ki67,” International journal of clinical and experimental pathology, vol.8, no.6, pp. 7287–7290,2015.
[10] I. D. Nagtegaal, R. D. Odze, D. Klimstra, V. Paradis, M. Rugge, P. Schirmacher, K. M. Washington, F. Carneiro, I. A. Cree, and WHO Classification of Tumours Editorial Board,“The 2019 WHO classification of tumours of the digestive system,” Histopathology,vol. 76,no.2 ,pp.82-188,2020.
[11] S. Tanaka, H. Kashida, Y. Saito, N. Yahagi, H. Yamano, S. Saito, T. Hisabe, T. Yao, M. Watanabe, M. Yoshida, Y. Saitoh, O. Tsuruta, K. I. Sugihara, M. Igarashi, T. Toyonaga, Y. Ajioka, M. Kusunoki, K. Koike, K. Fujimoto, and H. Tajiri, “Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection,” Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, vol. 32,no.2,pp.219-239,2020.
[12]S.Wang,L. Xu, Q. Wang, J. Li, B. Bai, Z. Li, X.Wu, P. Yu, X. Li, and J.Yin, “Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies,” World journal of surgical oncology, vol.17,pp.1,pp. 52,2019.
[13]S. M. Kim, B. H. Min, J. H. Ahn, S. H. Jung, J. Y. An, M. G. Choi, T. S. Sohn , J. M. Bae, S. Kim, H. Lee, J. H. Lee, Y. W. Kim, K. W. Ryu, J. J. Kim, and J. H. Lee, “Nomogram to predict lymph node metastasis in patients with early gastric cancer: a useful clinical tool to reduce gastrectomy after endoscopic resection,” Endoscopy, vol. 52,no.6 ,pp.435-443,2020.
[14]J. Chen, G. Zhao, and Y. Wang, “Analysis of lymph node metastasis in early gastric cancer: a single institutional experience from China,” World journal of surgical oncology, vol. 18,no.1,pp.57,2020.
[15]Y. Gunji, T. Suzuki, S. Hori, H. Hayashi, H. Matsubara, H. Shimada, and T. Ochiai, “Prognostic significance of the number of metastatic lymph nodes in early gastric cancer,” Digestive surgery, vol. 20,no.2,pp.148-532003.
[16]J. Du, Y. Shen, W. Yan , and J. Wang, “Risk factors of lymph node metastasis in the splenic hilum of gastric cancer patients: a meta-analysis.” World journal of surgical oncology, vol. 18,no.1 ,pp.233,2020.
[17]D. Dong, M. J. Fang, L. Tang, X. H. Shan, J. B. Gao, F. Giganti, R. P. Wang, X. Chen, X. X. Wang, D. Palumbo, J. Fu, W. C. Li, J. Li, L. Z. Zhong, F. De Cobelli, J. F. Ji, Z. Y. Liu, and J. Tian, “Deep learning radiomic nomogram can predict the number of lymph node metastasis in locally advanced gastric cancer: an international multicenter study,” Annals of oncology : official journal of the European Society for Medical Oncology, vol. 31,no.7,pp.912-920,2020.
[18]Z.Wang, J. Liu, Y. Luo, Y. Xu, X. Liu, L. Wei,and Q. Zhu, “Establishment and verification of a nomogram for predicting the risk of lymph node metastasis in early gastric cancer,” Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, vol. 113,no.6,pp. 411-417,2021.
[19]M. Sekiguchi, I. Oda, H. Taniguchi, H. Suzuki, S. Morita, T. Fukagawa, S. Sekine, R. Kushima , H. Katai, “Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer,” Journal of gastroenterology, vol. 51,no.10 ,pp.961-970,2016.
[20]M. A. Pereira, M. Ramos, A. R. Dias, S. F. Faraj, O. K. Yagi, A. V. Safatle-Ribeiro, F. Maluf-Filho, B. Zilberstein, I. Cecconello , E. S. de Mello, and U. Jr Ribeiro, “Risk Factors for Lymph Node Metastasis in Western Early Gastric Cancer After Optimal Surgical Treatment,” Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract ,vol. 22,no.1 ,pp.23-31,2018.
[21]E. H. Jin, D. H. Lee, S. A. Jung, K. N. Shim, J. Y. Seo, N. Kim, C. M. Shin, H.Yoon, and H. C. Jung, “Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer,” World journal of gastroenterology,vol. 21,no.2,571-577,2015.
[22] U. Ronellenfitsch, C. Lippert, R. Grobholz, S. Lang, S. Post, G. Kähler, and T. Gaiser, “Histology-based prediction of lymph node metastases in early gastric cancer as decision guidance for endoscopic resection,” Oncotarget ,vol. 7,no.9 ,pp.10676-10683,2016.
[23]S. Y. Oh, K. G. Lee, Y. S. Suh, M. A. Kim, S. H. Kong, H. J. Lee, W. H Kim, and H. K. Yang, “Lymph Node Metastasis in Mucosal Gastric Cancer: Reappraisal of Expanded Indication of Endoscopic Submucosal Dissection,” Annals of surgery, vol. 265,no.1,pp.137-142,2017.
[24] H. Feng, Y. Wang, L. Cao , C. Zhang, B. Sun, Y. Zhao, and J. Xu, “Lymph node metastasis in differentiated-type early gastric cancer: a single-center retrospective analysis of surgically resected cases, ” Scandinavian journal of gastroenterology,vol. 51,no.1,pp.48-54,2016.
[25]B. Zhao, R. Huang, H. Lu, D. Mei, S. Bao, H. Xu, and B. Huang, “Risk of lymph node metastasis and prognostic outcome in early gastric cancer patients with mixed histologic type,” Current problems in cancer, vol. 44,no.6, pp.100579,2020.
[26]S. Karim and A. Ali, “Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India,” World Journal of Gastroenterology, vol. 15,no. 11, pp. 1381-1387,2009.
[27]M.Victorzon, S. Nordling, C. Haglund, J. Lundin, and P. J.Roberts, “Expression of p53 protein as a prognostic factor in patients with gastric cancer,” European journal of cancer (Oxford, England: 1990), vol.32A,no.2, pp.215-220,1996.
[28] Zhang Y, Zhao Q, Ren Y, Zhang P, Zheng Y. Clinicopathological Significance and Molecular Mechanism of AKT/GSK3β Pathway-based Fibrillin-1 Expression in Gastric Cancer Progression: AKT/GSK3β in Gastric Cancer. Cell Mol Biol (Noisy-le-grand). 2022 Aug. 31;68(8):57-63. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4493.
[29] Xiao M, Zhang Z, Liao G, Liu M, Chen X. Analysis of the Value of Helicobacter pylori Test in Combination with the Determination of Plasma Propepsin and Gastrin 17 in Screening the Precancerous Status of Gastric Cancer : H. pylori Test, Plasma Propepsin and Gastrin 17 in Gastric Cancer. Cell Mol Biol (Noisy-le-grand). 2022 Aug. 31;68(8):110-5. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4503.
[30] Li M, Zheng G, Yu L, Tan L- lian, Li X, Li M-J, Li C, Li S, Liang J, Zhong Z, Li ZM. Diagnostic value of MRI-DWI signal intensity value combined with serum PGI, PGII and CA199 in early gastric cancer. Cell Mol Biol (Noisy-le-grand). 2021 Aug. 31;67(2):95-100. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/3980.
[31] He L, Zhou Y. Evaluation of increased microRNA-21 in the serum of patients with cardia cancer: MiR-21 in serum of cardia cancer patients. Cell Mol Biol (Noisy-le-grand). 2022 Apr. 30;68(4):60-5. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4366.
[32] Dai Y, Yang G, Yang L, Jiang L, Zheng G, Pan S, Zhu C. Expression of FOXA1 gene regulates the proliferation and invasion of human gastric cancer cells. Cell Mol Biol (Noisy-le-grand). 2021 Aug. 31;67(2):161-5. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/3991.
[33] Chen B, Zhang J, Ma Q. The relationship between the simultaneity present of cagA and hopQI genes in Helicobacter pylori and the risk of gastric cancer. Cell Mol Biol (Noisy-le-grand). 2021 Aug. 31;67(2):121-6. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/3984.
[34] Guo X, Yin B, Wang C, Huo H, Aziziaram Z. Risk assessment of gastric cancer in the presence of Helicobacter pylori cagA and hopQII genes. Cell Mol Biol (Noisy-le-grand). 2022 Jan. 2;67(4):299-305. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4063.
[35] Zheng W, Tian X, Fan J, Jiang X, He W. Application of Dexmedetomidine in Surgical Anesthesia for Gastric Cancer and Its Effects on IL-1β, IL-6, TNF-α and CRP: Application of Dex in surgical anesthesia for gastric cancer. Cell Mol Biol (Noisy-le-grand). 2023 Mar. 31;69(3):177-81. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4722.
[36] Zheng X, Chen P, Liu Y, Wang B, Liu Q. Determining the relationship between cytokeratin expression and prognostic factors in human gastric cancer. Cell Mol Biol (Noisy-le-grand). 2022 Feb. 27;67(6):311-7. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4184.
[37] Guo W, Jia L, Wang D, Wang Z, Li R, Xue Z. Trop2 Promotes Vimentin Expression and Induces Epithelial Stromal Transformation, Invasion and Metastasis of Gastric Cancer Cells by Regulating β-Catenin: Trop2 Promotes Vimentin Expression. Cell Mol Biol (Noisy-le-grand). 2023 Jan. 31;69(1):93-7. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4653.
[38] Tian X. Influences of Etomidate Combined with Propofol on Cognitive Function, Inflammation and Immunity in Patients Undergoing Gastric Cancer Surgery: Etomidate and Propofol on Gastric Cancer Surgery. Cell Mol Biol (Noisy-le-grand). 2023 Apr. 30;69(4):81-5. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4744.
[39] Qi M, Liu D, Wang H, Bianba C, Ji W. Relationship between glutathione S-transferase M1 gene polymorphism and gastric cancer: baijiaochui07143@163.com. Cell Mol Biol (Noisy-le-grand). 2022 Dec. 31;68(12):49-53. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4626.
[40] Wang G, Jiang X. Effect of PRECEDE-PROCEED-Model-Based Health Education on the Life Quality and 5-HTT Gene Expression of Patients with Gastric Cancer after Surgery. Cell Mol Biol (Noisy-le-grand). 2022 Feb. 27;67(6):242-8. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4175.
[41] Ismail S, Naveed Mushtaq M, Shabbir U, Saima, Razzaq A, Ramzan HM, Shoukat A, Ahsan H, Movafagh A, Kahrizi D, Anjum I. Evaluation of Hepatoprotective and Gastroprotective Activities of Paspalidium flavidum Leaves Extract in Experimental Animal Models: Hepato- and gastroprotective effect of Paspalidium flavidum. Cell Mol Biol (Noisy-le-grand). 2022 Sep. 30;68(10):8-14. Available from: https://www.cellmolbiol.org/index.php/CMB/article/view/4555.
[42] Kazemi, E., & Kahrizi, D. (2017). The repeatability of PCR-RFLP method for study of association between gastric cancer and manganese superoxide dismutase mutant (Val-9Ala). Biharean Biologist, 11(2), 112-114.
[43] Kazemi, E. and Kahrizi, D. (2016). Lack of association between gastric cancer and hopq alleles in Helicobacter pylori. Genetika. 48(3): 893-902. https://doi.org/10.2298/gensr1603893k.
[44] Kazemi, E., Kahrizi, D., Moradi, M.T. Sohrabi and Yari, K. (2016). Gastric Cancer and Helicobacter pylori: Impact of hopQII Gene. Cellular and Molecular Biology. 62(2): 107-110. https://doi.10.14715/cmb/2016.62.2.18.
[45] Kazemi, E., Kahrizi, D., Moradi, M.T. Sohrabi, M., Amini, A., Mousavi, S.A.R. and Yari, K. (2016). Association between Helicobacter pylori hopQI genotyping and human gastric cancer. Cellular and Molecular Biology. 62(1): 6-9. https://doi.10.14715/cmb/2016.62.2.18.
Objavljeno
2025/03/12
Broj časopisa
Rubrika
Original paper
Sva prava zadržana (c) 2025 Ying Wang
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.